These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction? Juliato CRT, Melotti IGR, Junior LCS, Britto LGO, Riccetto CLZ. J Sex Med; 2017 Jul; 14(7):904-909. PubMed ID: 28622875 [Abstract] [Full Text] [Related]
3. OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome. Balzarro M, Rubilotta E, Braga A, Bassi S, Processali T, Artibani W, Serati M. Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():228-231. PubMed ID: 29753213 [Abstract] [Full Text] [Related]
4. The impact of Mirabegron on sexual function in women with idiopathic overactive bladder. Gubbiotti M, Giannantoni A, Cantaluppi S, Coluccia AC, Ghezzi F, Serati M. BMC Urol; 2019 Jan 21; 19(1):7. PubMed ID: 30665388 [Abstract] [Full Text] [Related]
5. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Martin-Garcia M, Crampton J. Physiotherapy; 2019 Dec 21; 105(4):469-475. PubMed ID: 30862384 [Abstract] [Full Text] [Related]
6. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder. Salatzki J, Liechti MD, Spanudakis E, Gonzales G, Baldwin J, Haslam C, Pakzad M, Panicker JN. BJU Int; 2019 May 21; 123(5A):E20-E28. PubMed ID: 30552801 [Abstract] [Full Text] [Related]
7. Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis. Balzarro M, Rubilotta E, Mancini V, Trabacchin N, Oppezzi L, Li Marzi V, Fusco F, Serati M. Sex Med Rev; 2019 Oct 21; 7(4):565-574. PubMed ID: 31326358 [Abstract] [Full Text] [Related]
8. [Impact of overactive bladder on sexual function in women]. Del Rosso A, Pace G, Di Pierro ED, Masciovecchio S, Galatioto GP, Vicentini C. Urologia; 2011 Oct 21; 78(3):200-2. PubMed ID: 21786235 [Abstract] [Full Text] [Related]
9. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator. Kapur A, Aalami Harandi A, Hartman-Kenzler J, Kim J. Neurourol Urodyn; 2024 Apr 21; 43(4):959-966. PubMed ID: 38390786 [Abstract] [Full Text] [Related]
10. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation. Del Río-Gonzalez S, Aragon IM, Castillo E, Milla-España F, Galacho A, Machuca J, Lara MF, Herrera-Imbroda B. Urology; 2017 Oct 21; 108():52-58. PubMed ID: 28687483 [Abstract] [Full Text] [Related]
11. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome. Ramírez-García I, Kauffmann S, Blanco-Ratto L, Carralero-Martínez A, Sánchez E. Neurourol Urodyn; 2021 Jan 21; 40(1):295-302. PubMed ID: 33118624 [Abstract] [Full Text] [Related]
12. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, Ozden H, Ozisik Karaman H. Urology; 2016 Jan 21; 87():76-81. PubMed ID: 26436213 [Abstract] [Full Text] [Related]
13. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Rostaminia G, Chang C, Pincus JB, Sand PK, Goldberg RP. Int Urogynecol J; 2019 Oct 21; 30(10):1735-1745. PubMed ID: 30498931 [Abstract] [Full Text] [Related]
16. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report. Patidar N, Mittal V, Kumar M, Sureka SK, Arora S, Ansari MS. J Pediatr Urol; 2015 Dec 21; 11(6):351.e1-6. PubMed ID: 26279104 [Abstract] [Full Text] [Related]
17. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial. Preyer O, Umek W, Laml T, Bjelic-Radisic V, Gabriel B, Mittlboeck M, Hanzal E. Eur J Obstet Gynecol Reprod Biol; 2015 Aug 21; 191():51-6. PubMed ID: 26073262 [Abstract] [Full Text] [Related]
18. Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience. Signorello D, Seitz CC, Berner L, Trenti E, Martini T, Galantini A, Lusuardi L, Lodde M, Pycha A. J Sex Med; 2011 Apr 21; 8(4):1147-55. PubMed ID: 21269397 [Abstract] [Full Text] [Related]
19. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children. Barroso U, Viterbo W, Bittencourt J, Farias T, Lordêlo P. J Urol; 2013 Aug 21; 190(2):673-7. PubMed ID: 23422257 [Abstract] [Full Text] [Related]
20. Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study. Scaldazza CV, Morosetti C, Giampieretti R, Lorenzetti R, Baroni M. Int Braz J Urol; 2017 Aug 21; 43(1):121-126. PubMed ID: 28124534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]